SCHEMBL20199634

SCHEMBL20199634

c1ccc(-c2cc(-c3ccccc3)nc(-n3c4cc5c(cc4c4c6ccccc6ccc43)-c3ccccc3C53c4ccccc4C4(c5ccccc5-c5ccccc54)c4ccccc43)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.36
KDM4E B2RXH2 1/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.31
CYP1A2 P05177 2/20 0.31
CYP2C9 P11712 2/20 0.31
CYP2C19 P33261 2/20 0.31
CYP3A4 P08684 1/20 0.31
GAA P10253 1/20 0.31
AGTR1 P30556 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
NQO2 P16083 1/20 0.31
KMT2A Q03164 2/20 0.31
MAPK1 P28482 1/20 0.31
PTGES O14684 1/20 0.31
MEN1 O00255 1/20 0.30
LMNA P02545 1/20 0.30
MAPK10 P53779 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20199758 0.96 MAPT (0.36) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL20199597 0.95 MAPT (0.37) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL18119716 0.93 KDM4E (0.33) MAPTKDM4EALDH1A1HPGDPTGES
SCHEMBL20199633 0.91 KDM4E (0.31) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL20199629 0.87 MAPT (0.36) MAPTKDM4EALDH1A1HPGDNPSR1
SCHEMBL20199636 0.87 KDM4E (0.36) MAPTKDM4EALDH1A1HPGDKMT2A
SCHEMBL20199637 0.87 ALDH1A1 (0.39) MAPTKDM4EALDH1A1HPGDGAA
SCHEMBL23184913 0.86 KDM4E (0.33) MAPTKDM4EALDH1A1HPGD
SCHEMBL20199757 0.86 KDM4E (0.31) MAPTKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL18119714 0.86 KDM4E (0.31) MAPTKDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11001752-B2 Double spiro organic compound and organic electronic element comprising same LG CHEM, LTD. (KR) 2021-05-11 US disclosed
US-20180148640-A1 DOUBLE SPIRO ORGANIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-31 US disclosed
US-20180148640-A1 DOUBLE SPIRO ORGANIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-05-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11001752-B2 Double spiro organic compound and organic electronic element comprising same DCX, TERT, TELO2 MAPT 1276/4885KDM4E 1392/4885ALDH1A1 569/4885
US-20180148640-A1 DOUBLE SPIRO ORGANIC COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME DCX, TERT, TELO2 MAPT 1276/4885KDM4E 1392/4885ALDH1A1 569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.